Bioventix 

$26.80
110
+$0.03+0.1%Monday 13:05

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
139.47M
P/E Ratio
-
Dividend Yield
7.44%
Dividend
1.99

Upcoming

Dividends

7.44%Dividend Yield
Nov 2026
$1.05
Apr 2026
$0.95
Nov 2025
$1.05
Apr 2025
$0.93
Nov 2024
$1.10
10Y Growth
13.43%
5Y Growth
6.9%
3Y Growth
1.54%
1Y Growth
0.72%

Earnings

Oct 26Expected
Q3 2025
Q4 2025
Q3 2026
0.87
0.94
1.01
1.07
Expected EPS
0.874962
Actual EPS
0.994275

Financials

58.75%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
25.48MRevenue
14.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BVNXF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap187.95B
Abbott Laboratories offers diagnostic solutions and competes in the antibody space, overlapping with Bioventix's antibody development for diagnostics.
Danaher
DHR
Mkt Cap163.94B
Danaher Corporation, through its subsidiaries, provides professional, medical, industrial, and commercial products and services, including diagnostic solutions that compete with Bioventix.
Resmed
RMD
Mkt Cap33.69B
ResMed Inc. specializes in medical devices for respiratory disorders but also ventures into health diagnostics, indirectly competing with Bioventix's diagnostic technologies.
Bio-Rad Laboratories
BIO
Mkt Cap9.85B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, directly competing with Bioventix in the diagnostics sector.
Thermo Fisher Scientific
TMO
Mkt Cap259.44B
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, competing with Bioventix in the diagnostics and research market.
Qiagen NV
QGEN
Mkt Cap10.3B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the diagnostics market alongside Bioventix.
Bruker
BRKR
Mkt Cap9.41B
Bruker Corporation designs, manufactures, and distributes scientific instruments and analytical and diagnostic solutions, competing with Bioventix in the diagnostics and analytical solutions sector.
Waters
WAT
Mkt Cap90.45B
Waters Corporation produces analytical instruments, software, and services for the healthcare sector, including diagnostics, competing with Bioventix in the development of diagnostic solutions.
Agilent Technologies
A
Mkt Cap49.04B
Agilent Technologies, Inc. provides application-focused solutions in the life sciences, diagnostics, and applied chemical markets, competing with Bioventix in the diagnostics and research fields.

About

Bioventix PLC focuses on the development, manufacturing, and global provision of sheep monoclonal antibodies (SMAs) for various diagnostic purposes. The company's extensive product line features purified SMAs that facilitate testing for critical areas such as thyroid conditions, vitamin D deficiencies, cardiac health markers, detection of drugs of abuse, fertility assessments, infectious diseases, oncology, and other diverse medical indications. Additionally, Bioventix PLC offers tailored contract SMA development and specialized recombinant services. The London, UK-based firm was established in 2003.
Show More
CEO
Peter John Harrison
Employees
12
Country
United Kingdom
ISIN
GB00B4QVDF07
WKN
000A113DD

Listings

0 Comments

Share your thoughts

FAQs

What is Bioventix stock price today?▼
The current price of BVNXF is $26.80 USD — it has increased by +0.1% in the past 24 hours. Watch Bioventix stock price performance more closely on the chart.
What is Bioventix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Bioventix stocks are traded under the ticker BVNXF.
What is Bioventix market cap?▼
Today Bioventix has the market capitalization of 139.47M
When is the next Bioventix earnings date?▼
Bioventix is going to release the next earnings report on March 29, 2027.
What were Bioventix earnings last quarter?▼
BVNXF earnings for the last quarter are 0.99 USD per share, whereas the estimation was 0.87 USD resulting in a +13.64% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bioventix revenue for the last year?▼
Bioventix revenue for the last year amounts to 25.48M USD.
What is Bioventix net income for the last year?▼
BVNXF net income for the last year is 14.97M USD.
Does Bioventix pay dividends?▼
Yes, BVNXF dividends are paid semi-annual. The last dividend per share was 1.05 . As of today, Dividend Yield (FWD)% is 7.44%.
How many employees does Bioventix have?▼
As of November 22, 2026, the company has 12 employees.
In which sector is Bioventix located?▼
Bioventix operates in the Health & Wellness sector.
When did Bioventix complete a stock split?▼
Bioventix has not had any recent stock splits.
Where is Bioventix headquartered?▼
Bioventix is headquartered in Farnham, United Kingdom.